{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T05:56:25Z","timestamp":1743141385393,"version":"3.40.3"},"publisher-location":"Berlin, Heidelberg","reference-count":76,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783642554032"},{"type":"electronic","value":"9783642554049"}],"license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/82_2013_353","type":"book-chapter","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T08:27:19Z","timestamp":1389169639000},"page":"231-258","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["When, How, and Where can Oral Cholera Vaccines be Used to Interrupt Cholera Outbreaks?"],"prefix":"10.1007","author":[{"given":"John","family":"Clemens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Holmgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,9]]},"reference":[{"key":"353_CR1","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.vaccine.2008.12.036","volume":"27","author":"T Ahmed","year":"2009","unstructured":"Ahmed T, Svennerholm A-M, Al Tarique A, Sultana GNN, Qadri F (2009) Enhanced immunogenicity of an oral inactivated cholera vaccine in infants in Bangladesh obtained by zinc supplementation and by temporary withholding breast-feeding. Vaccine 27:1433\u20131439","journal-title":"Vaccine"},{"key":"353_CR2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S0140-6736(05)66550-6","volume":"366","author":"M Ali","year":"2005","unstructured":"Ali M, Emch M, von Seidlein L, Yunus M, Sack D, Rao M, Holmgren J, Clemens J (2005) Herd immunity conferred by killed oral cholera vaccines in Bangladesh. Lancet 366:44\u201349","journal-title":"Lancet"},{"key":"353_CR3","doi-asserted-by":"crossref","unstructured":"Ali M, Emch M, Yunus M, Sack D, Lopez Al, Holmgren J, Clemens J (2008) Vaccine herd protection of Bangladeshi infants and young children against cholera: implications for vaccine deployment and person-to-person transmission. Pediatr Infect Dis J 27:33\u201337","DOI":"10.1097\/INF.0b013e318149dffd"},{"key":"353_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2471\/BLT.11.093427","volume":"90","author":"M Ali","year":"2011","unstructured":"Ali M, Lopez A, Yu Y, Kim Y, Sah B, Maskery B, Clemens J (2011) Global burden of cholera. Bull World Health Organ 90:209\u2013218","journal-title":"Bull World Health Organ"},{"key":"353_CR5","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/cid\/cit009","volume":"56","author":"M Ali","year":"2013","unstructured":"Ali M, Sur D, Kanungo S, Sah B, Manna B, Puri M, Wierzba T, Donner A, Nair G, Bhattacharya S, Dhingra M, Deen J, Lopez A, Clemens J (2013) Herd protection by a bivalent-killed whole-cell oral cholera vaccine in the slums of Kolkata, India. Clin Infect Dis 56:1123\u20131131","journal-title":"Clin Infect Dis"},{"key":"353_CR6","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/S0140-6736(11)60273-0","volume":"377","author":"J Andrews","year":"2011","unstructured":"Andrews J, Basu S (2011) Transmission dynamics and control of cholera in Haiti: and epidemic model. Lancet 377:1248\u20131255","journal-title":"Lancet"},{"key":"353_CR7","doi-asserted-by":"publisher","first-page":"e1006","DOI":"10.1371\/journal.pntd.0001006","volume":"5","author":"D Anh","year":"2011","unstructured":"Anh D, Lopez A, Thiem V, Grahek S, Duong T, Park J, Kwon H, Favorov M, Hien V, Clemens J (2011) Use of oral cholera vaccines in an outbreak in Vietnam: a case control study. PLoS Negl Trop Dis5:e1006","journal-title":"PLoS Negl Trop Dis"},{"key":"353_CR8","first-page":"19","volume":"51","author":"J Azurin","year":"1974","unstructured":"Azurin J, Alverin M (1974) Field evaluation of environmental sanitation measures against cholera. Bull WHO 51:19\u201326","journal-title":"Bull WHO"},{"key":"353_CR9","unstructured":"Benenson A (1976) Review of the experience with whole-cell and somatic antigen vaccines. In: Symposium on cholera. US-Japan cooperative medical science program. Sapporo, Japan, pp 228\u2013252"},{"key":"353_CR10","doi-asserted-by":"crossref","first-page":"L06403","DOI":"10.1029\/2011GL046823","volume":"38","author":"E Bertuzzo","year":"2011","unstructured":"Bertuzzo E, Mari L, Righetto L et al (2011) Prediction of the spatial evolution and effect of control measures for the unfolding Haiti cholera outbreak. Geophys Res Lett 38:L06403","journal-title":"Geophys Res Lett"},{"key":"353_CR11","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1016\/j.vaccine.2003.11.070","volume":"22","author":"P Calain","year":"2004","unstructured":"Calain P, Chaine J, Johnson E et al (2004) Can oral cholera vaccination play a role in controlling a cholera outbreak? Vaccine 22:2444\u20132451","journal-title":"Vaccine"},{"key":"353_CR12","doi-asserted-by":"publisher","first-page":"4890","DOI":"10.1016\/j.vaccine.2005.10.006","volume":"24","author":"P Cavailler","year":"2006","unstructured":"Cavailler P, Lucas M, Perroud V et al (2006) Feasibility of a mass vaccination campaign using a two dose oral cholera vaccine in an urban cholera-endemic setting in Mozambique. Vaccine 24:4890\u20134895","journal-title":"Vaccine"},{"key":"353_CR13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1586\/14760584.7.4.431","volume":"7","author":"C-L Chaignat","year":"2008","unstructured":"Chaignat C-L, Monti V, Soepardi J et al (2008) Cholera in disasters: do vaccines prompt new hopes? Expert Rev Vaccines 7:431\u2013435","journal-title":"Expert Rev Vaccines"},{"key":"353_CR14","doi-asserted-by":"publisher","first-page":"7081","DOI":"10.1073\/pnas.1102149108","volume":"10","author":"D Chao","year":"2011","unstructured":"Chao D, Halloran E, Longini I (2011) Vaccination strategies for epidemic cholera in Haiti with implications for the developing world. Proc Nat Acad Sci 10:7081\u20137085","journal-title":"Proc Nat Acad Sci"},{"key":"353_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/infdis\/154.1.175","volume":"154","author":"J Clemens","year":"1986","unstructured":"Clemens J, Jertborn M, Sack D, Stanton B et al (1986) Effect of neutralization of gastric acid on immune responses to oral B subunit killed whole cell cholera vaccine. J Infect Dis 154:175\u2013178","journal-title":"J Infect Dis"},{"key":"353_CR16","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/S0140-6736(88)92189-7","volume":"2","author":"JD Clemens","year":"1988","unstructured":"Clemens JD, Sack D, Harris JR, Chakraborty J, Khan MR, Stanton B, Ali M, Ahmed F, Yunus M, Kay B, Khan MU, Rao MR, Svennerholm A\u2013M, Holmgren J (1988) Impact of B subunit killed whole\u2013cell and killed whole\u2013cell\u2013only oral vaccines against cholera upon treated diarrhoeal illness and mortality in an area endemic for cholera. Lancet 2:1375\u20131378","journal-title":"Lancet"},{"key":"353_CR17","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/infdis\/158.2.372","volume":"158","author":"J Clemens","year":"1988","unstructured":"Clemens J, Sack D, Harris J, Chakraborty J, Neogy P, Stanton B, Huda N, Khan MU, Kay BA, Khan MR, Ansaruzzaman M, Yunus M, Rao MR, Svennerholm A\u2013M, Holmgren J (1988) Cross\u2013protection by B subunit\u2013whole cell cholera vaccine against diarrhoea associated with heat labile toxin\u2013producing enterotoxigenic Escherichia coli: results of a large\u2013scale field trial. J Infect Dis 158:372\u2013377","journal-title":"J Infect Dis"},{"key":"353_CR18","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1093\/infdis\/159.4.770","volume":"159","author":"J Clemens","year":"1989","unstructured":"Clemens J, Sack D, Harris J, Chakraborty J, Khan MR, Huda S, Ahmed F, Gomes J, Rao M, Svennerholm A\u2013M, Holmgren J. ABO blood groups and cholera: new oCTBervations on specificity of risk and modification of vaccine efficacy. J Infect Dis 159:770\u2013773","journal-title":"J Infect Dis"},{"key":"353_CR19","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/0140-6736(90)90080-O","volume":"335","author":"J Clemens","year":"1990","unstructured":"Clemens J, Sack DA, Harris J, van Loon F, Chakraborty J, Ahmed F, Rao MR, Khan MR, Yunus M, Huda N, Stanton B, Kay B, Walter S, Eeckels R, Svennerholm A-M, Holmgren J (1990) Field trial of oral cholera vaccines in Bangladesh: results from long-term follow-up. Lancet 335:270\u2013273","journal-title":"Lancet"},{"key":"353_CR20","doi-asserted-by":"crossref","unstructured":"Clemens J, Spriggs D, Sack D (1994) Public health considerations for the use of cholera vaccines in cholera control programs. In: Wachsmith IK, Blake P, Olsvik O. Vibrio cholera and cholera: molecular to global perspectives. ASM Press, Washington pp 425\u2013442","DOI":"10.1128\/9781555818364.ch28"},{"key":"353_CR21","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/jama.1996.03530290060038","volume":"275","author":"J Clemens","year":"1996","unstructured":"Clemens J, Brenner R, Rao M, Lowe C (1996) Evaluating new vaccines for developing countries: efficacy or effectiveness? J Am Med Assoc 275:390\u2013397","journal-title":"J Am Med Assoc"},{"key":"353_CR22","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/0140-6736(90)90080-O","volume":"335","author":"J Clemens","year":"1999","unstructured":"Clemens J, Sack DA, Harris J, van Loon F, Chakraborty J, Ahmed F, Rao MR, Khan MR, Yunus M, Huda N, Stanton B, Kay B, Walter S, Eeckels R, Svennerholm A-M, Holmgren J (1999) Field trial of oral cholera vaccines in Bangladesh: results from long-term follow-up. Lancet 335:270\u2013273","journal-title":"Lancet"},{"key":"353_CR23","unstructured":"Costa A (2009) Establishing a cholera vaccine stockpile: What do we need? Focus on neglected tropical infectious diseases: integrating vaccines into global cholera control efforts. Annecy, France"},{"key":"353_CR24","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.3201\/eid1711.110822","volume":"17","author":"K Date","year":"2011","unstructured":"Date K, Vitari A, Hyde T, Mintz E, Donavaro-Holladay M, Henry A, Tappero J, Roels T, Abrams J, Burkholder B, Ruiz-Matus C, Andrus J, Dietz V (2011) Considerations for oral cholera vaccine use during outbreak after earthquake in Haiti, 2010\u20132011. Emerg Inf Dis 17:2105\u20132112","journal-title":"Emerg Inf Dis"},{"key":"353_CR25","first-page":"127","volume":"64","author":"B Deb","year":"1986","unstructured":"Deb B, Sircar B, Senoupta P, De S, Mondal S, Gupta D, Saha N, Ghosh S, Mitra U, Pal S (1986) Studies on interventions to prevent El Tor cholera transmission in urban slums. Bull WHO 64:127\u20131231","journal-title":"Bull WHO"},{"key":"353_CR26","first-page":"949","volume":"77","author":"F Dorlencourt","year":"1999","unstructured":"Dorlencourt F, Legros D, Paquet C, Neira M, Ivanoff B, Le Saout E (1999) Effectiveness of mass vaccination with WC\/rCTB cholera vaccine during an epidemic in Adjumani district. Uganda Bull World Health Org 77:949\u2013950","journal-title":"Uganda Bull World Health Org"},{"key":"353_CR27","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/oxfordjournals.aje.a113498","volume":"116","author":"R Glass","year":"1982","unstructured":"Glass R, Becker S, Huq I, Stoll B, Khan MU, Merson M, Lee J, Black R (1982) Endemic cholera in rural Bangladesh, 1966-80. Amer J Epidemiol 116:959\u2013970","journal-title":"Amer J Epidemiol"},{"key":"353_CR28","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/S0140-6736(10)62172-1","volume":"376","author":"J Harris","year":"2010","unstructured":"Harris J, LaRocque R, Charles R et al (2010) Cholera\u2019s western front. Lancet 376:1961\u20131965","journal-title":"Lancet"},{"key":"353_CR29","doi-asserted-by":"publisher","first-page":"e1743","DOI":"10.1371\/journal.pntd.0001743","volume":"6","author":"R Hashim","year":"2012","unstructured":"Hashim R, Khatib A, Enwere G, Park J, Reyburn R, Ali M, Chang N, Kim D, Ley B, Thriemer K, Lopez A, Clemens J, Deen J, Shin S, Schaetti C, Hutubessy R, Aguado T, Kieny M, Sack D, Obaro S, Shaane A, Ali S, Sahah A, von Seidlein L, Jiddawi M (2012) Safety of recombinant cholera toxin B subunit, killed whole cell (rCTB-WC) oral cholera vaccine in pregnancy. PLoS Neglect Trop Dis 6:e1743","journal-title":"PLoS Neglect Trop Dis"},{"key":"353_CR30","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/0264-410X(92)90324-D","volume":"10","author":"J Holmgren","year":"1992","unstructured":"Holmgren J, Svennerholm AM, Jertborn M, Clemens J et al (1992) An oral B subunit-killed whole cell vaccine against cholera. Vaccine 10:911\u2013914","journal-title":"Vaccine"},{"key":"353_CR31","unstructured":"International Vaccine Institute (2012) An investment case for the accelerated introduction of oral cholera vaccines. International vaccine institute. Seoul, Korea"},{"key":"353_CR32","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1016\/S0140-6736(12)60832-0","volume":"379","author":"I Ivers","year":"2012","unstructured":"Ivers I, Farmer P, Pape W (2012) Oral cholera vaccines and integrated cholera control in Haiti. Lancet 379:2026\u20132028","journal-title":"Lancet"},{"key":"353_CR33","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/j.1524-4733.2009.00562.x","volume":"12","author":"M Jeuland","year":"2009","unstructured":"Jeuland M, Cook J, Poulos C, Clemens J, Whittington D (2009) Cost-effectiveness of new generation oral cholera vaccines: a multi-site analysis. Value Health 12:899\u2013908","journal-title":"Value Health"},{"key":"353_CR34","doi-asserted-by":"publisher","first-page":"6887","DOI":"10.1016\/j.vaccine.2009.09.008","volume":"27","author":"S Kanungo","year":"2009","unstructured":"Kanungo S, Paisley A, Lopez AL, Bhattacharya M, Manna B, Kim DR, Han SH, Attridge S, Carbis R, Rao R, Holmgren J, Clemens JD, Sur D (2009) Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata India: A randomized, placebo-controlled trial. Vaccine 27:6887\u20136893","journal-title":"Vaccine"},{"key":"353_CR35","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/0923-2508(90)90128-D","volume":"141","author":"JB Kaper","year":"1990","unstructured":"Kaper JB, Levine MM (1990) Recombinant attenuated Vibrio cholerae strains used as live oral vaccines. Res Microbiol 141: 901\u2013906","journal-title":"Res Microbiol"},{"key":"353_CR36","doi-asserted-by":"crossref","unstructured":"Khatib A, Ali M, von Seidlein L, Kim D, Hashim R, Reyburn R, Ley B, Thriemer K, Enwere G, Hutubessy R, Aguado MT, Kieny M-P, Wierzba T, Ali S, Saleh A, Clemens J, Jiddawi M, Deen J (2012) Effectiveness of an oral cholera vaccine in Zanzibar: findings from a large mass vaccination campaign and observational cohort study. Lancet Infect Dis [Epub ahead of print]","DOI":"10.1016\/S1473-3099(12)70196-2"},{"key":"353_CR37","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0140-6736(88)90120-1","volume":"1","author":"M Levine","year":"1988","unstructured":"Levine M, Kaper J, Herrington D et al (1988) Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR. Lancet 1:467\u2013704","journal-title":"Lancet"},{"key":"353_CR38","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1097\/00002030-199406000-00009","volume":"8","author":"D Lewis","year":"1994","unstructured":"Lewis D, Gilks C, Ojoo S et al (1994) Immune response following oral administration of cholera toxin B subunit to HIV-1-infected UK and Kenyan subjects. AIDS 8:779\u2013785","journal-title":"AIDS"},{"key":"353_CR39","doi-asserted-by":"publisher","first-page":"e336","DOI":"10.1371\/journal.pmed.0040336","volume":"4","author":"I Longini","year":"2007","unstructured":"Longini I, Nizam A, Ali M, Yunus M, Shenvi N, Clemens J (2007) Controlling endemic cholera with oral vaccines. PLoS Med 4:e336","journal-title":"PLoS Med"},{"key":"353_CR40","doi-asserted-by":"crossref","unstructured":"Lopez Al, Clemens J, Deen J, Jodar L (2008) Cholera vaccines for the developing world. Hum Vaccines 4:165\u2013169","DOI":"10.4161\/hv.4.2.5122"},{"key":"353_CR41","doi-asserted-by":"crossref","unstructured":"Lucas M, Deen JL, von Seidlein L, Wang X-Y, Ampuero J, Puri M, Ali M, Ansaruzzaman M, Amos J, Cavallier P, Guerin P, McChesney M, Mahoudeau C, Kahozi P, Chaignat C-Barreto A, Songane F, Clemens JD (2005) The effectiveness of an internationally licensed, two dose oral cholera vaccine when given in a mass vaccination campaign in Beira, Mozambique. N Engl J Med 352:757\u2013767","DOI":"10.1056\/NEJMoa043323"},{"key":"353_CR42","unstructured":"Medecins sans Frontieres (2013) Cholera epidemic escalates along Sierra Leone and Guinea border. www.doctorswithoutborders.org. WeCTBite Accessed 30 Jan 2013"},{"key":"353_CR43","unstructured":"Ministere de la Santa Publique et de la population (2012) Rapport journalier MSPP du 01 Avril 2012. Port au Prince. http:\/\/www.mspp.gouv.ht\/site\/index.php. Accessed 1 Oct 2012"},{"key":"353_CR44","unstructured":"Mintz E, Popovic T, Blake P. Transmission of Vibrio cholera 01. In: Wachsmith IK, Blake P, Olsvik O. Vibrio cholera and cholera: molecular to global perspectives. ASM Press, Washington, pp 425\u2013442"},{"key":"353_CR45","doi-asserted-by":"crossref","first-page":"8767","DOI":"10.1073\/pnas.1019712108","volume":"108","author":"Z Mukandavire","year":"2011","unstructured":"Mukandavire Z, Liao S, Wang J, Gaff H, Smith DL, Glenn Morris J (2011) Estimating the reproductive numbers for the 2008\u20132009 cholera outbreaks in Zimbabwe. Proc Nat Acad Sci USA 108:8767\u20138772","journal-title":"Proc Nat Acad Sci USA"},{"key":"353_CR46","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1001\/jama.279.7.521","volume":"279","author":"A Naficy","year":"1998","unstructured":"Naficy A, Rao M, Paquet C, Antona D, Sorkin A, Clemens J. Treatment and vaccination strategies to control cholera in Sub-Saharan refugee settings. J Amer Med Assoc. 1998; 279: 521-5.","journal-title":"J Amer Med Assoc"},{"key":"353_CR47","doi-asserted-by":"publisher","first-page":"F145","DOI":"10.1097\/00002030-199814000-00001","volume":"12","author":"M Ortigao-de-Sampaio","year":"1998","unstructured":"Ortigao-de-Sampaio M, Shattock R, Hayes R et al (1998) Increase in plasma viral load oral cholera immunization of HIV-infected subjects. AIDS 12:F145\u2013F150","journal-title":"AIDS"},{"key":"353_CR48","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/0140-6736(91)92590-X","volume":"338","author":"H Peltola","year":"1991","unstructured":"Peltola H, Siitonen A, Kyronseppa H, Simula I, Hilal M, Ksonen P, Ktaaja M, Cadoz M (1991) Prevention of travellers\u2019 diarrhea by oral B subunit\/whole cell cholera vaccine. Lancet 338:1285\u20131289","journal-title":"Lancet"},{"key":"353_CR49","first-page":"63","volume":"76","author":"C Perry","year":"1998","unstructured":"Perry C, Plowe C, Koumare B, Bougoudogo F et al (1998) A single dose of live oral cholera vaccine CVD 103Hg-R is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali. Bull World Health Organ 76:63\u201371","journal-title":"Bull World Health Organ"},{"issue":"1","key":"353_CR50","doi-asserted-by":"crossref","first-page":"e952","DOI":"10.1371\/journal.pntd.0000952","volume":"5","author":"R Reyburn","year":"2011","unstructured":"Reyburn R, Deen J, Grais R, Bhattacharya S, Sur D, Lopez A, Jiddawi M, Clemens J, von Seidlein L (2011) The case for reactive oral cholera vaccinations. PLoS Negl Trop Dis 5(1):e952","journal-title":"PLoS Negl Trop Dis"},{"key":"353_CR51","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1016\/S0264-410X(00)00006-2","volume":"18","author":"EE Richie","year":"2000","unstructured":"Richie EE, Punjabi NH, Sidharta YY et al (2000) Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area. Vaccine 18:2399\u20132410","journal-title":"Vaccine"},{"key":"353_CR52","first-page":"299","volume":"21","author":"D Sack","year":"2003","unstructured":"Sack D (2003) When should cholera vaccine be used in cholera endemic areas? J Health Popul Nutr 21:299\u2013303","journal-title":"J Health Popul Nutr"},{"key":"353_CR53","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0140-6736(03)15328-7","volume":"363","author":"DA Sack","year":"2004","unstructured":"Sack DA, Sack RB, Nair GB, Siddique AK (2004) Cholera. Lancet 363:223\u2013233","journal-title":"Lancet"},{"key":"353_CR54","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/S0140-6736(94)90755-2","volume":"344","author":"J Sanchez","year":"1994","unstructured":"Sanchez J, Vasquez B, Begue R, Meza R, Castellares G, Cabezas C, Watts D, Sadoff J, Taylor D (1994) Protective efficacy of oral whole cell-recombinant B subunit cholera vaccine in Peruvian military recruits. Lancet 344:1273\u20131276","journal-title":"Lancet"},{"key":"353_CR55","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4269\/ajtmh.2008.79.414","volume":"79","author":"S Sasaki","year":"2008","unstructured":"Sasaki S, Suzuki H, Igarashi K, Tambatamba B, Mulenga P (2008) Spatial analysis of risk factor of cholera outbreak for 2003-2004 in a peri-urban area of Lusaka, Zambia. Am J Trop Med Hyg 79:414\u2013421","journal-title":"Am J Trop Med Hyg"},{"key":"353_CR56","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1093\/cid\/cir141","volume":"52","author":"S Shin","year":"2011","unstructured":"Shin S, Desai S, Sah BK, Clemens J (2011) Oral vaccines against cholera. Clin Infect Dis 52:1343\u20131349","journal-title":"Clin Infect Dis"},{"key":"353_CR57","doi-asserted-by":"crossref","first-page":"640","DOI":"10.4269\/ajtmh.2009.80.640","volume":"80","author":"A Shultz","year":"2009","unstructured":"Shultz A, Omollo JO, Burke H et al (2009) Cholera outbreak in Kenyan refugee camp: risk factors for illness and importance of sanitation. Am J Trop Med Hyg 80:640\u2013645","journal-title":"Am J Trop Med Hyg"},{"key":"353_CR58","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1093\/infdis\/165.6.1042","volume":"165","author":"P Su-Arehawaratana","year":"1992","unstructured":"Su-Arehawaratana P, Singharaj P, Taylor DN et al (1992) Safety and immunogenicity of different immunization regimens of CVD 103-HgR live oral cholera vaccine in soldiers and civilians in Thailand. J Infect Dis  165:1042\u20131048","journal-title":"J Infect Dis"},{"key":"353_CR59","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/0140-6736(92)92231-4","volume":"340","author":"M Suharyono","year":"1992","unstructured":"Suharyono M, Simanjuntak C, Witham N et al (1992) Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5\u20139-year-old Indonesian children. Lancet 340:689\u2013694","journal-title":"Lancet"},{"key":"353_CR60","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/S0140-6736(09)61297-6","volume":"374","author":"D Sur","year":"2009","unstructured":"Sur D, Lopez A, Kanungo S, Paisley A, Manna B, Al M, Niyogi S, Park JK, Sarkar B, Pur M, Kim D, Deen J, Holmgren J, Carbis R, Rao R, Nguyen TV, Donner A, Ganguly NK, Nair GB, Bhattacharya SK, Clemens JD (2009) Protection and safety of a modified, killed whole cell oral cholera vaccine in India: a cluster-randomized, double-blind, placebo-controlled trial. Lancet 374:1694\u2013702","journal-title":"Lancet"},{"key":"353_CR61","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1128\/iai.13.3.735-740.1976","volume":"13","author":"AM Svennerholm","year":"1976","unstructured":"Svennerholm AM, Holmgren J (1976) Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin\/toxoid. Infect Immun 13:735\u2013740","journal-title":"Infect Immun"},{"key":"353_CR62","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/infdis\/149.6.884","volume":"149","author":"AM Svennerholm","year":"1984","unstructured":"Svennerholm AM, Jertborn M, Gothefors L et al (1984) Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine. J Infect Dis 149:884\u2013893","journal-title":"J Infect Dis"},{"key":"353_CR63","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1093\/infdis\/166.4.837","volume":"166","author":"CO Tacket","year":"1992","unstructured":"Tacket CO, Losonsky G, Nataro JP et al (1992) Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR. J Infect Dis 166:837\u2013841","journal-title":"J Infect Dis"},{"key":"353_CR64","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1128\/IAI.67.12.6341-6345.1999","volume":"67","author":"CO Tacket","year":"1999","unstructured":"Tacket CO, Cohen MB, Wasserman SS et al (1999) Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El Tor Inaba three months after vaccination. Infect Immun 67:6341\u20136345","journal-title":"Infect Immun"},{"key":"353_CR65","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.1016\/j.vaccine.2006.03.008","volume":"24","author":"VD Thiem","year":"2006","unstructured":"Thiem VD, Deen JL, von Seidlein L, Do GC, Dang DA, Park JK, Ali M, Danovaro-Holliday MC, Nguyen DS, Nguyen TH, Holmgren J, Clemens JD (2006) Long-term effectiveness against cholera of oral killed whole-cell vaccine produced in Vietnam. Vaccine 24:4297\u20134303","journal-title":"Vaccine"},{"key":"353_CR66","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0140-6736(96)06107-7","volume":"349","author":"DD Trach","year":"1997","unstructured":"Trach DD, Clemens JD, Ke NT et al (1997) Field trial of a locally produced, killed, oral cholera vaccine in Vietnam. Lancet 349:231\u2013235","journal-title":"Lancet"},{"key":"353_CR67","doi-asserted-by":"publisher","first-page":"593","DOI":"10.7326\/0003-4819-154-9-201105030-00334","volume":"154","author":"AR Tuite","year":"2011","unstructured":"Tuite AR, Tien J, Eisenberg M, Earn D, Ma J, Fishman D (2011) Cholera epidemic in Haiti, 2010: using a transmission model to explain spatial spread of disease and identify optimal control interventions. Ann Internal Med 154:593\u2013601","journal-title":"Ann Internal Med"},{"key":"353_CR68","unstructured":"WHO (1999) Potential use of oral cholera vaccines in emergency situations. Report of a meeting, Geneva, 12\u201313 May 1999, WHO 1999 (CDS\/CSR\/EDC\/99.4)"},{"key":"353_CR69","unstructured":"WHO (2007) Cholera 2006. Wkly Epidemiol Rec 82:273\u2013284"},{"key":"353_CR70","unstructured":"WHO (2008) Cholera 2007. Wkly Epidemiol Rec 83:261\u2013284"},{"key":"353_CR71","first-page":"117","volume":"85","author":"WHO","year":"2010","unstructured":"WHO (2010) Cholera vaccines: WHO position paper. Wkly Epidemiol Rep 85:117\u2013128","journal-title":"Wkly Epidemiol Rep"},{"key":"353_CR72","first-page":"289","volume":"87","author":"WHO (2012a) Cholera","year":"2011","unstructured":"WHO (2012a) Cholera 2011. Wkly Epidemiol Bull 87:289\u2013304","journal-title":"Wkly Epidemiol Bull"},{"key":"353_CR73","unstructured":"WHO (2012b) WHO consultation on oral cholera vaccine (OCV) stockpile strategic framework: potential objectives and possible policy options. WHO\/IVB\/12.05"},{"key":"353_CR74","unstructured":"WHO (2012c) WHO Technical working group on creation of an oral cholera vaccine stockpile. WHO\/HSE\/PED\/2012.2"},{"key":"353_CR75","first-page":"2","volume":"80","author":"DD Trach","year":"2002","unstructured":"Trach DD, Cam PD, Ke NY (2002) Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam. Bull World Health Organ 80:2\u20138","journal-title":"Bull World Health Organ"},{"key":"353_CR76","unstructured":"World Health Organization Expert Committee on Biological Standardization (2001) Guidelines for the production and control of inactivated oral cholera vaccines. WHO Tech Rep Ser 924:129\u2013149"}],"container-title":["Current Topics in Microbiology and Immunology","Cholera Outbreaks"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/82_2013_353","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T21:59:02Z","timestamp":1676843942000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/82_2013_353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"ISBN":["9783642554032","9783642554049"],"references-count":76,"URL":"https:\/\/doi.org\/10.1007\/82_2013_353","relation":{},"ISSN":["0070-217X","2196-9965"],"issn-type":[{"type":"print","value":"0070-217X"},{"type":"electronic","value":"2196-9965"}],"subject":[],"published":{"date-parts":[[2013]]},"assertion":[{"value":"9 January 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}